| Name | Title | Contact Details |
|---|---|---|
Justin Harris |
Chief Technology Officer | Profile |
ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed`s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm in female breast cancer patients.
MatriCal is a Spokane, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Rhode Island Blood Center was founded in 1979 as a non-profit community blood center. Our goal is to ensure that all Rhode Islanders have immediate access to a safe and plentiful blood supply. The blood center achieves its goals by constantly
Bone Bank Allografts is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Certol International is a Commerce City, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.